Omeprazole is a potent proton pump inhibitor for the treatment of various acid-related gastrointestinal disorders. simple, selective and rapid reversed phase high performance liquid chromatographic (RP-HPLC) method for the analysis of Omeprazole has been developed and validated. The separation was achieved from HPLC column (ZORBAX, XDB, C-18 (150×4.6 mm, 5 micron) with a mobile phase consisting of HPLC grade acetonitrile and phosphate buffer solution (pH 7.4) in the ratio of (60:40 v/v) at a flow rate of 0.5 ml/min and runtime 10 min with UV detector at 302nm. The method was specific and it was observed that no interference with diluents. The proposed method was accurate with 100.95% recovery omeprazole and precise (% RSD of area of system precision, % RSD of assay of method precision were found to be 0.14% and 0.37% respectively). From the linearity study the correlation coefficient is found to be 0.9988, which indicated that the method was linear over 25% to 175% range. The method was found robust for possible changes. Therefore, this method can be used as a more convenient and efficient option for the analysis of Omeprazole to establish the quality of the drug substance during routine analysis with consistent and reproducible results.
Published in | American Journal of Chemical Engineering (Volume 6, Issue 1) |
DOI | 10.11648/j.ajche.20180601.11 |
Page(s) | 1-6 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2018. Published by Science Publishing Group |
Omeprazole, HPLC, Validation, Mobile Phase
[1] | Indian Pharmacopoeia, Vol. II, Govt. of India, Ministry of Health and Family Welfare. New Delhi; Published by The Controller of Publications; 1996. |
[2] | Forte, JG; Lee, (1977). HC "Gastric adenosine triphosphates: A review of their possible role in HCl secretion". Gastroenterology 73 (4 Pt 2): 921–6. PMID20386. |
[3] | Snaeder, W, (1996). Drug prototypes and their exploitation. Wiley. pp. 414–5. |
[4] | Hemenway, Jeffrey Nm, (2007). "Case Study: Omeprazole (Prilosec®)". Prodrugs. Biotechnology: Pharmaceutical Aspects. pp. 1313–21. doi:10.1007/978-0-387-49785-3_49. ISBN978-0-387-49782-2. |
[5] | Shin, Jai Moo; Munson, Keith; Vagin, Olga; Sachs, George, (2008). "The gastric HK-ATPase: Structure, function, and inhibition". Pflügers Archiv - European Journal of Physiology 457 (3): 609–22. doi:10.1007/s00424-008-0495-4. PMC3079481. PMID18536934. |
[6] | British Pharmacopoeia, (2013). Vol.1, the British Pharmacopoeia Commission, London. |
[7] | United States Pharmacopia, 30-NF-25 31 (4) 1100. |
[8] | Sweetman SC. Martindale, (2002) – The Complete Drug Reference, (3 rd Edition) Pharmaceutical Press, London, 1241-1243. |
[9] | Girish Malhotra, (2010). "Chemical Process Simplification: Improving Productivity and Sustainability" ch 5 to be published John Wiley & Sons. |
[10] | Kalakonda Sri Nataraj, Mohammad Badrud Duza, Kalyani Pragallapati, Dussa Kiran Kumar, (2012). International Current Pharmaceutical Journal, 1(11): 366-369. |
APA Style
Mahmoud Mohamed Ali, Eshtiag Abdalla Ibrahim, Mohamed N. Abdalaziz. (2018). Development and Validation for RP-HPLC Method of Assay of Omeprazole Capsules Formulation. American Journal of Chemical Engineering, 6(1), 1-6. https://doi.org/10.11648/j.ajche.20180601.11
ACS Style
Mahmoud Mohamed Ali; Eshtiag Abdalla Ibrahim; Mohamed N. Abdalaziz. Development and Validation for RP-HPLC Method of Assay of Omeprazole Capsules Formulation. Am. J. Chem. Eng. 2018, 6(1), 1-6. doi: 10.11648/j.ajche.20180601.11
AMA Style
Mahmoud Mohamed Ali, Eshtiag Abdalla Ibrahim, Mohamed N. Abdalaziz. Development and Validation for RP-HPLC Method of Assay of Omeprazole Capsules Formulation. Am J Chem Eng. 2018;6(1):1-6. doi: 10.11648/j.ajche.20180601.11
@article{10.11648/j.ajche.20180601.11, author = {Mahmoud Mohamed Ali and Eshtiag Abdalla Ibrahim and Mohamed N. Abdalaziz}, title = {Development and Validation for RP-HPLC Method of Assay of Omeprazole Capsules Formulation}, journal = {American Journal of Chemical Engineering}, volume = {6}, number = {1}, pages = {1-6}, doi = {10.11648/j.ajche.20180601.11}, url = {https://doi.org/10.11648/j.ajche.20180601.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajche.20180601.11}, abstract = {Omeprazole is a potent proton pump inhibitor for the treatment of various acid-related gastrointestinal disorders. simple, selective and rapid reversed phase high performance liquid chromatographic (RP-HPLC) method for the analysis of Omeprazole has been developed and validated. The separation was achieved from HPLC column (ZORBAX, XDB, C-18 (150×4.6 mm, 5 micron) with a mobile phase consisting of HPLC grade acetonitrile and phosphate buffer solution (pH 7.4) in the ratio of (60:40 v/v) at a flow rate of 0.5 ml/min and runtime 10 min with UV detector at 302nm. The method was specific and it was observed that no interference with diluents. The proposed method was accurate with 100.95% recovery omeprazole and precise (% RSD of area of system precision, % RSD of assay of method precision were found to be 0.14% and 0.37% respectively). From the linearity study the correlation coefficient is found to be 0.9988, which indicated that the method was linear over 25% to 175% range. The method was found robust for possible changes. Therefore, this method can be used as a more convenient and efficient option for the analysis of Omeprazole to establish the quality of the drug substance during routine analysis with consistent and reproducible results.}, year = {2018} }
TY - JOUR T1 - Development and Validation for RP-HPLC Method of Assay of Omeprazole Capsules Formulation AU - Mahmoud Mohamed Ali AU - Eshtiag Abdalla Ibrahim AU - Mohamed N. Abdalaziz Y1 - 2018/01/09 PY - 2018 N1 - https://doi.org/10.11648/j.ajche.20180601.11 DO - 10.11648/j.ajche.20180601.11 T2 - American Journal of Chemical Engineering JF - American Journal of Chemical Engineering JO - American Journal of Chemical Engineering SP - 1 EP - 6 PB - Science Publishing Group SN - 2330-8613 UR - https://doi.org/10.11648/j.ajche.20180601.11 AB - Omeprazole is a potent proton pump inhibitor for the treatment of various acid-related gastrointestinal disorders. simple, selective and rapid reversed phase high performance liquid chromatographic (RP-HPLC) method for the analysis of Omeprazole has been developed and validated. The separation was achieved from HPLC column (ZORBAX, XDB, C-18 (150×4.6 mm, 5 micron) with a mobile phase consisting of HPLC grade acetonitrile and phosphate buffer solution (pH 7.4) in the ratio of (60:40 v/v) at a flow rate of 0.5 ml/min and runtime 10 min with UV detector at 302nm. The method was specific and it was observed that no interference with diluents. The proposed method was accurate with 100.95% recovery omeprazole and precise (% RSD of area of system precision, % RSD of assay of method precision were found to be 0.14% and 0.37% respectively). From the linearity study the correlation coefficient is found to be 0.9988, which indicated that the method was linear over 25% to 175% range. The method was found robust for possible changes. Therefore, this method can be used as a more convenient and efficient option for the analysis of Omeprazole to establish the quality of the drug substance during routine analysis with consistent and reproducible results. VL - 6 IS - 1 ER -